Peter C. Melby
Medical Service
Audie L. Murphy Division
South Texas Veterans Health Care System
San Antonio
USA
Name/email consistency: high
- Vaccination against cutaneous leishmaniasis: current status. Melby, P.C. Am. J. Clin. Dermatol (2002)
- Recent developments in leishmaniasis. Melby, P.C. Curr. Opin. Infect. Dis. (2002)
- The hamster as a model of human visceral leishmaniasis: progressive disease and impaired generation of nitric oxide in the face of a prominent Th1-like cytokine response. Melby, P.C., Chandrasekar, B., Zhao, W., Coe, J.E. J. Immunol. (2001)
- Leishmania donovani p36(LACK) DNA vaccine is highly immunogenic but not protective against experimental visceral leishmaniasis. Melby, P.C., Yang, J., Zhao, W., Perez, L.E., Cheng, J. Infect. Immun. (2001)
- Leishmania donovani: evolution and architecture of the splenic cellular immune response related to control of infection. Melby, P.C., Tabares, A., Restrepo, B.I., Cardona, A.E., McGuff, H.S., Teale, J.M. Exp. Parasitol. (2001)
- Identification of vaccine candidates for experimental visceral leishmaniasis by immunization with sequential fractions of a cDNA expression library. Melby, P.C., Ogden, G.B., Flores, H.A., Zhao, W., Geldmacher, C., Biediger, N.M., Ahuja, S.K., Uranga, J., Melendez, M. Infect. Immun. (2000)
- Regional differences in the cellular immune response to experimental cutaneous or visceral infection with Leishmania donovani. Melby, P.C., Yang, Y.Z., Cheng, J., Zhao, W. Infect. Immun. (1998)
- Cloning of Syrian hamster (Mesocricetus auratus) cytokine cDNAs and analysis of cytokine mRNA expression in experimental visceral leishmaniasis. Melby, P.C., Tryon, V.V., Chandrasekar, B., Freeman, G.L. Infect. Immun. (1998)